| |
all times are approximate and subject to change without notice |
| |
Pre-conference Workshop - Tuesday, May 29, 2012 |
| 12:00p |
Registration |
| Title |
For an additional
$495 industry or $295 academic, you can
register
for the pre-conference workshop:
Clinical Sequencing Workshop |
1:00p
1:30p |
Emerging Next-Generation Sequencing Technologies and its Clinical Applications
- Thomas Scholl, Integrated Genetics / LabCorp
The Implementation of Next-Generation Sequencing in a CLIA Laboratory -
Issues and Challenges
- Matthew Ferber, Mayo Clinic
|
| 2:10p |
Networking and Refreshment Break |
2:40p
3:20p
|
Translation of NextGen sequencing from research applications to
a standardized lab developed test in a CLIA environment
- Andrew Grupe, Celera
Measuring and Ensuring Quality in NGS -
Tina Hambuch, Illumina Clinical Services |
| 4:00p |
Pre-Conference Workshop Concludes |
| |
|
| |
Day 1 - Wednesday, May 30, 2012 |
| 7:00a |
Registration and Continental Breakfast |
| |
Six Concurrent Tracks |
| Track Titles |
2nd Genomic & Proteomic Drug Discovery |
2nd Next Generation Sequencing |
Genome-wide Patnering & Dealmaking |
7th Protein Kinases in Drug Discovery |
3rd RNAi Research and Development |
2nd Epigenetics in Drug Discovery |
| 8:00a |
Session:
Pharmaco-omics
|
Session:
Applications of NGS Platfoms |
Session:
Partnering for Personalized Medicines |
Session:
Trends in Drug Design – Structure / Selectivity / Pathway / Epigenetic |
Session:
RNAi Delivery Methods |
Session:
Epigenetic Mechanisms
|
| |
10:00am
Networking and Refreshment Break |
9:30am
Networking and Refreshment Break |
10:05a
and
10:30a |
Session:
Pharmaco-omics
|
Session:
Novel Sequencing Strategies
|
Session:
Technologies in Genomics and Diagnostic Partnering |
Session:
Trends in Drug Design – Structure / Selectivity / Pathway / Epigenetic |
Session:
RNAi Delivery Methods |
Session:
Role of Epigenetics in Human Diseases
|
| 12:10p |
Lunch On Your Own |
| 1:40p |
Session:
Advances in Genomic Medicine
|
Session:
Next Next Generation Sequencing
|
Session:
Companion Diagnostics Partnering Business Models |
Session:
Oncology Kinases & Inhibitor Candidates |
Session:
Therapeutic, Diagnostics and Clinical Applications |
Session:
Role of Epigenetics in Human Diseases
|
| |
2:55p Networking and Refreshment Break |
3:20p Networking and Refreshment Break |
3:20p
and
3:50p |
Session:
Identification and Validation of Drug Targets
|
Session:
Next Next Generation Sequencing
|
Session:
The Future of Pharma-Diagnostic Partnerships |
Session:
Oncology Kinases & Inhibitor Candidates |
Session:
Therapeutic, Diagnostics and Clinical Applications |
Session:
Drug Discovery in Epigenetics
|
| 5:30p |
Networking Reception and Poster Session |
| |
|
| |
Day 2 - Thursday, May 31, 2012 |
| 7:30a |
Continental Breakfast |
| |
Plenary Keynote Session |
| 8:00a |
George Church, Ph.D.
Professor of Genetics, Director of the Center for Computational Genetics
Harvard Medical School |
Craig C. Mello, Ph.D.
Nobel Laureate
Blais Professor in Molecular Medicine
University of Massachusetts Medical School
Howard Hughes Investigator
HHMI |
|
9:30a |
Networking and Refreshment Break |
| Track Titles |
2nd Genomic & Proteomic Drug Discovery |
2nd Next Generation Sequencing |
Genome-wide Patnering & Dealmaking |
7th Protein Kinases in Drug Discovery |
3rd RNAi Research and Development |
2nd Epigenetics in Drug Discovery |
| 10:15a |
Session:
Systems Biology for Drug and Diagnostic Development |
Session:
Data Analysis and Management
|
Session:
Reimbursement Issues & Trends
Session:
Genome-wide ELSI |
Session:
Other Kinases & Inhibitor Candidate |
Session:
Target Discovery and Validation |
Session:
Enabling Diagnostics and Technologies for Epigenetics Drug Discovery
|
| 12:05p |
Lunch Provided by GTC |
|
1:00p |
Session:
Systems Biology for Drug and Diagnostic Development |
Session:
Sequencing Technology and Software
|
Panel Discussion:
Genome-wide Industry-Academic Collaboration |
Session:
Overcoming Challenges in Kinase Drug Development |
Session:
MicroRNA and Diseases |
Session:
Preclinical and Clinical Development in Epigenetics
|
|
3:30p |
Conferences Conclude |
| |
all times are approximate and subject to change without notice |
